Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 801–900 of 1,000
Tang, R., Dang, M., Zhang, X., Tao, J., Shi, W., Lu, W. M., Yu, R., Su, X., Tang, Y., & Teng, Z. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.11.190 · Cited by 6
Huang, K., Xu, H., Han, L., Xu, R.-M., Xu, Z., & Xie, Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1054614 · Cited by 6
Pourmadadi, M., Ghohrodi, A. R., Savari, Z., Talebi, E., Ahamdi, I., Rahdar, A., & Pandey, S. (2023) · Next Nanotechnology · doi:10.1016/j.nxnano.2023.100018 · Cited by 10
Li, L., Huang, K., Tu, Z., Zhu, X., Li, J., Lei, K., Luo, M., Wang, P., Gong, C., Long, X., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738651 · Cited by 6
Shaik, R., Suthar, K., Balija, C., Aleem, S., Syeda, F. S., Syeda, S., & Begum, S. (2025) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1177/10849785251362585 · Cited by 10
Rodrigues‐Jesus, J., Canadas‐Sousa, A., Vilhena, H., & Dias‐Pereira, P. (2025) · Veterinary Sciences · doi:10.3390/vetsci12100959 · Cited by 6
Melatonin and breast cancer: a mathematical modeling approach in blind women
Enver, A., & Ayaz, F. (2025) · Bulletin of Biomathematics · doi:10.59292/bulletinbiomath.1783080 · Cited by 5
Mechanisms Underlying Immunotherapy Resistance in Microsatellite-stable Colorectal Cancer
Di, J., Liu, J., & Zhang, X. (2025) · Oncology Advances · doi:10.14218/ona.2025.00021 · Cited by 5
Emran, T. B., Amin, M. A., Rab, S. O., Jahnavi, P., Vodeti, R., Gupta, J. K., Arjun, U. V. N. V., Umamaheswari, T. N., Balaji, P., Dayalan, G., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04651-5 · Cited by 5
Advances in nano‑molybdenum oxide: structural engineering progress in tumor theranostics
Sun, Y., Yang, D., Hu, Y., Ding, H., Gai, S., Ansari, A. A., Ma, Y., & Yang, P. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217377 · Cited by 5
Figueroa, S., Reyes, N., Tiwari, R. K., & Geliebter, J. (2026) · Cancers · doi:10.3390/cancers18030412 · Cited by 5
Wang, K., He, H., & Feng, X. (2022) · Journal of Immunology Research · doi:10.1155/2022/2359349 · Cited by 13
Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer
Guo, X.-Q., & Hua, Y. (2022) · Neoplasma · doi:10.4149/neo_2022_220611n619 · Cited by 5
Matuszczak, S., Szczepanik, K., Grządziel, A., Drzyzga, A., Cichoń, T., Czapla, J., Pilny, E., & Smolarczyk, R. (2023) · Biomedicines · doi:10.3390/biomedicines11061773 · Cited by 5
Zhang, S., Zhang, Y., Song, X., Wang, X., Quan, L., Xu, P., Zhao, L., Song, W., Liu, Q., & Zhou, X. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150686 · Cited by 6
Xu, N., Gao, Z., Wu, D., Chen, H., Zhang, Z., Zhang, L., Wang, Y., Lu, X., Xu, Y., Liu, X., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70189 · Cited by 5
Moradi, S., Sarikhani, P., Albadr, R. J., Taher, W. M., Alwan, M., Jawad, M. J., Mushtaq, H., & Vakilzadehian, N. (2025) · Discover Oncology · doi:10.1007/s12672-025-02076-3 · Cited by 6
Modeling breast cancer dynamics through modulable small Vessel Environment Bioreactor (sVEB)
Maiullari, F., Ceraolo, M. G., Presutti, D., Fratini, N., Galbiati, M., Fasciani, A., Giżyński, K., Bousselmi, S., Megiorni, F., Marchese, C., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123441 · Cited by 9
Exosomal long non-coding RNAs in human malignancies: biological functions and clinical applications
Almouh, M. (2025) · Medical Oncology · doi:10.1007/s12032-025-02845-8 · Cited by 5
Lu, Q., Zhang, Y., Chen, X., Gu, W., Ji, X.-R., & Chen, Z. (2021) · Medicine · doi:10.1097/md.0000000000024957 · Cited by 5
Chen, L., Zhang, M., Zhou, J., Zhang, L., & Liang, C. Y. (2022) · Cancer Medicine · doi:10.1002/cam4.4776 · Cited by 6
Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer
Chang, S., Zhang, L., Chen, D., Wei, H., Qi, W., Zhang, P., Guo, H., & Sun, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1054157 · Cited by 5
Tian, Y., Hu, Q., Zhang, R., Zhou, B., Xie, D., Wang, Y., & Yang, L. (2023) · MedComm – Oncology · doi:10.1002/mog2.21 · Cited by 5
Zhang, Q., Yang, L., He, X., Dang, Z., Kuang, X., Xiong, Y., Zhu, J., Huang, Z., & Li, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1074955 · Cited by 7
Qiu, J., Wang, Z., Zhao, L., Zhang, P., Xu, Y., & Xia, Q. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1201155 · Cited by 5
Progress in investigating the relationship between Schlafen5 genes and malignant tumors
Tu, T., Yuan, Y., Liu, X., Liang, X. T., Yang, X., & Yang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1248825 · Cited by 5
Wang, G., Si, Y., Liu, J., Wang, W., & Yang, J. (2023) · Academic Radiology · doi:10.1016/j.acra.2023.08.007 · Cited by 6
Li, N., Zhang, G., Zhan, J., & Yu, D. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02875e · Cited by 5
Yang, J., Liu, Y., Geng, Q., & Wang, B. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09240-y · Cited by 5
Ma, J., Wang, Y., Zhao, Z., Xiong, Z.-Y., Zhang, Z., Cai, J., & Guo, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1483987 · Cited by 5
High temperature requirement A1 in cancer: biomarker and therapeutic target
Chen, M., Yang, S., Wu, Y., Zhao, Z., Zhai, X., & Dong, D. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02203-4 · Cited by 6
Cui, S., Zhang, M., Bai, S., Bi, Y., Cong, S., Jin, S., Li, S., He, H., & Zhang, J. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/1847700 · Cited by 5
Takahashi, T., Ando, Y., Ichikawa, H., Tsuneyama, K., & Hijikata, T. (2023) · FEBS Journal · doi:10.1111/febs.16802 · Cited by 5
Explore the impact of hypoxia-related genes (HRGs) in Cutaneous melanoma
Ke, G., Cheng, N., Sun, H., Meng, X., & Xu, L. (2023) · BMC Medical Genomics · doi:10.1186/s12920-023-01587-8 · Cited by 5
Li, J., Wu, F., Su, L., Zhu, H., Yao, J., & Zhang, M. (2023) · Oncology Letters · doi:10.3892/ol.2023.13969 · Cited by 5
Zhao, X., Guo, X., Mei, P., Qiu, W., Luo, Z., Lin, Q., Lu, Y., Yin, H. H., Wang, S., Liu, H., et al. (2023) · Nano Research · doi:10.1007/s12274-023-6030-2 · Cited by 5
Abbas, Z. K., Naser, N. H., & Atiya, R. N. (2023) · Polski Merkuriusz Lekarski · doi:10.36740/merkur202305112 · Cited by 5
EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening
Cappelletto, A., Alfì, E., Volf, N., Vu, T. V. A., Bortolotti, F., Ciucci, G., Vodret, S., Fantuz, M., Perin, M., Colliva, A., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02942-4 · Cited by 5
Recent Advances in Head and Neck Tumor Microenvironment–Based Therapy
Macha, M. A., Wani, N. A., Ganai, R. A., Bhat, A. A., Hamid, A., Hashem, S., Haris, M., Chauhan, S. S., Zargar, M. A., & Batra, S. K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_2 · Cited by 5
D-Mannose Slows Glioma Growth by Modulating Myeloperoxidase Activity
Motlagh, N. J., Wang, C., Kuellenberg, E. G., Wojtkiewicz, G. R., Schmidt, S., & Chen, J. W. (2021) · Cancers · doi:10.3390/cancers13246360 · Cited by 5
Editorial: Therapeutic Opportunities and Innovative Biomarkers in Tumor Microenvironment
Xu, K., Rahmatpanah, F. B., & Jia, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.803414 · Cited by 6
Hua, X., Chen, Y., Niu, H., Li, X., Gai, X., & Cui, G. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08365-1 · Cited by 4
Genomic Profiling of the Hallmarks of Cancer
Dib, E. G., Bekkerman, M., Abbas, J., Shanmugasundaram, M., Banerjee, D., He, G., Slabý, O., Elsherif, M. A., & Ge, M. (2024) · Precision Oncogenomics · doi:10.1080/28354311.2023.2264176 · Cited by 5
Hybrid nano-stimulator for specific amplification of oxidative stress and precise tumour treatment
Yang, T., Liu, Z., Zhang, T., & Liu, Y. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2349112 · Cited by 4
Ma, F., Miao, X., Lin, Y., Luo, X., Chen, T., Ni, Z., & Wang, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114498 · Cited by 4
Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Anwar, S., Khan, M. S., Yadav, D. K., Shahwan, M. J., & Shamsi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-94825-1 · Cited by 4
Liwei, Z., Lu, H., Wenpeng, Z., Weijie, Y., Sifang, C., Zhang, B., Li, Z., Xin, G., Li, W., Mao, J., et al. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2529643 · Cited by 5
Precision Medicine: Transforming Cancer Research through Targeted Therapies
Agrawal, S. K., Jain, S. S., & Agrawal, M. (2025) · Current Genomics · doi:10.2174/0113892029357275250721125929 · Cited by 6
Yang, Y., Liu, R., Lv, H., Zhao, Y., Wang, X., Wang, Z., Li, J., & Shi, D. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114113 · Cited by 7
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy
Awadasseid, A., Wu, M., Zhang, F., Song, Y., Wu, Y., & Zhang, W. (2025) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/0118715206393267250912114756 · Cited by 5
Microbiome-modulated immunotherapy in oncology: Current applications and future prospects
Liu, Y., Miao, K., & Yang, X. (2026) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2026.01.001 · Cited by 4
Role of tumor microenvironment in regulator of tumor progression and immunotherapy
周平平 (2026) · Discover Oncology · doi:10.1007/s12672-026-04421-6 · Cited by 5
Stimuli-Responsive Carbon Nanotubes for On-Demand Cancer Therapy: A Review
Radha, M., Chaudhari, R. S., Raut, M. K., Mamatha, M., Arora, D., Patel, A., Khan, S., & Kumar, P. (2026) · AAPS PharmSciTech · doi:10.1208/s12249-026-03391-w · Cited by 5
Angolkar, M., Paramshetti, S., Patil, D., Spandana, K. M. A., Osmani, R. A. M., Gangadharappa, H. V., Fatease, A. M. A., Alamri, A. H., Hani, U., & Rajput, A. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156453 · Cited by 5
Zhao, Q., Shen, C., Wei, J., & Zhao, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.899407 · Cited by 4
Are tumour-associated carbonic anhydrases genuine therapeutic targets for photodynamic therapy?
Merabti, A., Richeter, S., Supuran, C. T., Clément, S., & Winum, J. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2255380 · Cited by 6
Rodríguez-Bejarano, O. H., Roa, L., Vargas-Hernández, G., Botero-Espinosa, L., Parra-López, C., & Patarroyo, M. A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189064 · Cited by 4
Karami, F., Osanloo, M., Alipanah, H., Zarenezhad, E., Moghimi, F., & Asad, A. G. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04673-1 · Cited by 5
Jalali, P., Aliyari, S., Etesami, M., Niasar, M. S., Taher, S., Kavousi, K., Mojarad, E. N., & Salehi, Z. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01512-y · Cited by 4
Ashok, G., Alasmari, A. F., Alasmari, F. F., Livingstone, P. G., Anbarasu, A., & Ramaiah, S. (2024) · Discover Oncology · doi:10.1007/s12672-024-01531-x · Cited by 4
Sun, Y., Li, Z., Liu, J., Xiao, Y., Pan, Y., Lv, B., Wang, X., & Lin, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1507375 · Cited by 4
Recent advances in biomimetic nanodelivery systems for the treatment of glioblastoma
Yuan, Z., Li, J., & Na, Q. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114668 · Cited by 6
Brake, K., Matus-Meza, A.-S., Rawat, P., Rikhtechi, P., Sadi, K. S., & Garrison, J. C. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.109031 · Cited by 8
Xing, C., Hu, W., & Zhao, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06936-y · Cited by 7
Nanotechnology Application and Intellectual Property Right Prospects of Mammalian Cell Culture
Rachamalla, H. K., Mukherjee, A., & Paul, M. K. (2022) · Biochemistry · doi:10.5772/intechopen.99146 · Cited by 6
Igbo, B. T., Linge, A., Frosch, S., Suckert, T., Stolz-Kieslich, L., Löck, S., Kumaravadivel, M. S., Welsch, T., Weitz, J., Sommer, U. J., et al. (2022) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2022.08.001 · Cited by 4
Lü, J., Zheng, G., Dong, A., Chang, X., Cao, X., Liu, M., Shi, X., Wang, C., Yang, Y., & Jia, X. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.990034 · Cited by 4
Yao, G., Huang, J., Zhang, Q., Hu, D., Feng, Y., & Han, G. (2023) · Immunotherapy · doi:10.2217/imt-2022-0104 · Cited by 4
The Comparative Invasiveness of Endometriotic Cell Lines to Breast and Endometrial Cancer Cell Lines
Ellis, K. B., & Wood, R. (2023) · Biomolecules · doi:10.3390/biom13061003 · Cited by 5
Gil-Edo, R., Royo, S., Cardá, M., & Falomir, E. (2023) · Pharmaceuticals · doi:10.3390/ph16060808 · Cited by 4
Tian, Y., Dong, J., & Li, L. (2023) · Life · doi:10.3390/life13071599 · Cited by 4
Tian, Q.-S., Cheng, J., & Bao, Z.-J. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2903104 · Cited by 4
Interweaving Tumor Heterogeneity into the Cancer Epigenetic/Metabolic Axis
Leung, J. Y., Chia, K., Ong, D. S. T., & Taneja, R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7942 · Cited by 4
[Research Progress of Cancer-associated Fibroblasts in Lung Cancer].
Huang, C., Xu, J., & Li, Z. (2020) · PubMed Central · doi:10.3779/j.issn.1009-3419.2020.102.16 · Cited by 4
Firing up the Tumor Microenvironment with Nanoparticle-Based Therapies
Pan, Y., Song, X., Wang, Y., & Wei, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091338 · Cited by 6
Targeting tumor microenvironment for breast cancer treatment
Mir, M. A., & Haq, B. U. (2022) · Elsevier eBooks · doi:10.1016/b978-0-443-18696-7.00008-7 · Cited by 4
Liang, X., Li, C., Fan, M., Zhang, W., Liu, L., Zhou, J., Hu, L., & Zhai, Z. (2023) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01085-2 · Cited by 4
Molecular Modeling of Nanoparticles
Bıçak, B., Gök, B., Kecel‐Gunduz, S., & Budama‐Kilinc, Y. (2022) · Springer eBooks · doi:10.1007/978-981-16-5180-9_23 · Cited by 4
Laser Direct Write Bioprinting Enriched Cell Types in the Breast Tumor MicroenvironmentPreprint
Saksena, J., Burow, M. E., & Chrisey, D. B. (2023) · doi:10.36227/techrxiv.22080866.v1 · Cited by 4
Wu, D., Guan, X., Yang, T., Yan, J., Zhu, B., Zhou, J., Guo, Y., & Lu, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102176 · Cited by 7
Pediatric tumor microenvironment: developmental dynamics and therapy resistance
George, N. G., Rishi, B., Dhanda, H., Joseph, G. T., Swain, S. K., Kaur, M., Kushwaha, N., Kamal, R., Tanwar, P., Zaheer, S., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1663975 · Cited by 3
Bioengineering Stem Cell-Derived Glioblastoma Organoids: A Comprehensive Review
Avera, A. D., & Kim, Y. (2025) · Pharmaceuticals · doi:10.3390/ph18121830 · Cited by 3
Unraveling the microbiome’s role in breast cancer progression and treatment response
Taki, A. G., Shareef, A., Arora, V., Oweis, R. J., Jyothi, S. R., Singh, U., Sahoo, S., Chauhan, A. S., Alimova, F., Sameer, H. N., et al. (2025) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2025.101264 · Cited by 3
Wang, Q., Liu, Z., & Jin, K. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s581940 · Cited by 4
Gandhi, S., Razif, M. F. M., Othman, S., Chakraborty, S., & Rashid, N. N. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.12933 · Cited by 3
Lu, Y., Allegri, G., & Huskens, J. (2023) · Small · doi:10.1002/smll.202206596 · Cited by 3
Wan, L., Li, Y., Pan, W., Yong, Y., Yang, C., Li, C., Zhao, X., Li, R., Yue, W., & Yan, X. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1232875 · Cited by 3
Wang, Y., Jin, Q., Zhang, S., & Wang, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01388-w · Cited by 3
Chen, Y.-C., Zheng, W.-Z., Liu, C., Zhao, Y.-Q., Li, J., Du, Z.-S., Zhai, T., Lin, H., Shi, W., Cai, S.-Q., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03496-x · Cited by 3
Nano-Sized Liposomes for Click-Chemistry-Based Selective Guiding of Immune Cells to Neuroblastoma
Arroyo-Nogales, A., Jiménez‐Falcao, S., Megías, D., Ramírez, M. R., & Baeza, A. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c00475 · Cited by 3
Joshi, M., & Patel, B. M. (2025) · Springer eBooks · doi:10.1007/978-981-97-9230-6_17 · Cited by 3
Aparajay, P., Madhyastha, H., Altamimi, M. A., Dev, A., Hussain, A., & Bhowmik, S. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03102-x · Cited by 3
Inhibition of autotaxin activity with IOA ‐289 decreases fibrosis in mouse E0771 breast tumors
Tang, X., Khan, H., Niewola‐Staszkowska, K., Wuest, F. R., & Brindley, D. N. (2025) · International Journal of Cancer · doi:10.1002/ijc.35471 · Cited by 3
Tumor microenvironment in squamous cell lung cancer – histological and immunohistochemical study
Cîmpeanu, O. L., Osman, A., Georgescu, A.-M., ANDREI, E. C., Oprea, B., Mateescu, V. O., Pătru, L., Mogoantă, C. A., Tănase, I., Ciocâlteu, A., et al. (2025) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.66.1.14 · Cited by 4
Li, J., Li, H., Zhang, C., Zhang, C., Jiang, L., Wang, H., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.732841 · Cited by 4
Cox, M. C., Mendes, R. G. P. R., Halwachs, K. N., Domenici, G., Brito, C., & Boghaert, E. R. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2216016 · Cited by 3
Self-citationThe clinical significance of CD44v6 in malignant and benign primary bone tumors
Hosseini, A., Eghtedari, A. R., Mirzaei, A., Babaheidarian, P., Nekoufar, S., Khademian, N., Jamshidi, K., & Tavakoli‐Yaraki, M. (2023) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-023-06738-7 · Cited by 3
Efficacy of depatuxizumab mafodotin (ABT-414) in preclinical models of head and neck cancer
Mani, L., Naveed, A., McAdoo, A., Rosenthal, E. L., & Hom, M. E. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae014 · Cited by 3
Sex-specific and sex hormonal-related differences in melanoma microenvironment
Attorre, S., Ugolini, F., Lana, D., Giovannini, M. G., & Massi, D. (2024) · EJC Skin Cancer · doi:10.1016/j.ejcskn.2024.100266 · Cited by 3
Piroozkhah, M., Zabihi, M. R., Jalali, P., & Salehi, Z. (2024) · Cancer Reports · doi:10.1002/cnr2.70087 · Cited by 4
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.